GliaCure Secures $5,800,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a0c66c3-d89e-401f-9395-d283fbefcadf - Date
8/5/2014 - Company Name
GliaCure - Mailing Address
234 Causeway St. Boston, MA 02114 USA - Company Description
GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets. - Website
http://www.gliacure.com - Transaction Type
Venture Equity - Transaction Amount
$5,800,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
